Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Cancer of Granulosa Cells

imatinib mesylate has been researched along with Cancer of Granulosa Cells in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aleshin, AA; Allina, DO; Baranova, MP; Barbara, VS; Kamashev, DE; Kochergina-Nikitskaya, IN; Makovskaia, LA; Poddubskaya, EV; Sekacheva, MI; Suntsova, MV1
Grijuela, B; Guadalupi, V; Martinelli, F; Raspagliesi, F1
Alexiadis, M; Chu, S; Fuller, PJ1
Baker, AC; Barnes, MN; Conner, MG; Kimball, KJ; Matthews, KS; Rocconi, RP1

Other Studies

4 other study(ies) available for imatinib mesylate and Cancer of Granulosa Cells

ArticleYear
Personalized prescription of imatinib in recurrent granulosa cell tumor of the ovary: case report.
    Cold Spring Harbor molecular case studies, 2019, Volume: 5, Issue:2

    Topics: Adult; Female; Granulosa Cell Tumor; Humans; Imatinib Mesylate; Neoplasm Recurrence, Local; Precision Medicine; Treatment Outcome

2019
Third-line chemotherapy with tyrosine kinase inhibitor (imatinib mesylate) in recurrent ovarian granulosa cell tumor: case report.
    The journal of obstetrics and gynaecology research, 2011, Volume: 37, Issue:12

    Topics: Antineoplastic Agents; Benzamides; Female; Granulosa Cell Tumor; Humans; Imatinib Mesylate; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Treatment Outcome

2011
Expression, mutational analysis and in vitro response of imatinib mesylate and nilotinib target genes in ovarian granulosa cell tumors.
    Gynecologic oncology, 2008, Volume: 108, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Apoptosis; Benzamides; Cell Growth Processes; Cell Line, Tumor; DNA Mutational Analysis; Female; Gene Expression Profiling; Genes, fms; Granulosa Cell Tumor; Humans; Imatinib Mesylate; Membrane Proteins; Middle Aged; Ovarian Neoplasms; Piperazines; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2008
Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors.
    Reproductive sciences (Thousand Oaks, Calif.), 2008, Volume: 15, Issue:7

    Topics: Adolescent; Adult; Aged; Benzamides; Child; Drug Delivery Systems; Epithelium; Female; Gene Expression Regulation, Neoplastic; Granulosa Cell Tumor; Humans; Imatinib Mesylate; Middle Aged; Ovarian Neoplasms; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Stromal Cells; Young Adult

2008